Interstitial Lung Disease Trial, Recruiting NCT07486206 Sponsor: Hospital de Granollers Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT07486206
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You have been diagnosed with a condition called interstitial lung disease (ILD), which is a group of conditions that cause scarring or inflammation in the lungs.
  • You are currently taking medication to slow lung scarring (antifibrotic therapy), medication to calm the immune system (immunosuppressive therapy), or both, as part of your regular ILD treatment.
  • You are already being regularly seen and monitored at the hospital or clinic running this study.
  • You are able to attend the follow-up appointments required by the study.
  • You are able to understand and sign a consent form agreeing to take part.

Who may not be able to join:

  • You are unable to attend the required study visits for practical or logistical reasons unrelated to your health (for example, travel difficulties).
  • You are currently unwell or your condition is unstable, such as having a respiratory infection, a sudden worsening of your lung disease, heart failure, or another acute illness that would interfere with the study visits.
  • You are already taking part in another clinical trial that changes how often you have appointments or how your follow-up is structured.
  • You have a cognitive impairment (such as difficulties with memory or understanding) that would prevent you from giving consent or completing study questionnaires.
  • You do not wish to take part or do not agree to allow your data to be collected.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital de Granollers
Registry
ClinicalTrials.gov
Start date
9 March 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Total Follow-Up Time Burden (Home-to-Home and In-Hospital Time)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov